How much does Hep C medication cost?

How much does Hep C medication cost?

But they come at a price — a steep one. A 2018 study found that a single pill of one hepatitis C drug cost $1,000. The total was $84,000 for its 12-week course of treatment. Another drug cost $23,600 per month.

How much is Mavyret cost?

Abbvie has priced Mavyret at $13,200 per month, or $26,400 per treatment course, before discounts. Although this is still expensive, Macyret is priced significantly lower than other hepatitis C treatments.

How much does a 8-week treatment of Mavyret cost?

by The list price of Mavyret (glecaprevir and pibrentasvir) tablets for a 4-week supply is $13,200 or $26,400 per 8-week treatment course, according to AbbVie, the manufacturer. However, your out-of-pocket cost may be significantly less based on your public or private insurance coverage and copay.

How much is Harvoni per pill?

Meet Harvoni, which launched in October and costs $1,125 per pill, or $94,500 for a 12-week course of treatment. The drug comes from Gilead Sciences, which earlier this year broke records with $2.3 billion in first quarter sales of Sovaldi.

How do you pay for hep C treatment?

Funding Resources Available to Hep C Patients

  1. Pharmaceutical Programs.
  2. The American Liver Foundation (ALF)
  3. NeedyMeds.
  4. Help-4-Hep.
  5. The HealthWell Foundation.
  6. The Pharmaceutical Research and Manufacturers of America (PhRMA)
  7. The Patient Access Network (PAN) Foundation.
  8. The Patient Advocate Foundation.

Does insurance pay for hep C treatment?

Most health insurance plans require treatment for HCV to be medically necessary. Whether or not treatment is medically necessary depends on each plan’s coverage policy.

Why is Harvoni so expensive?

At press time Harvoni was priced at $87,800 — an increase over 2016 by $13,800. The price jump could be due to its extremely high effectiveness rate (since patients no longer need treatment after finishing the 12- to 24-week supply.

How expensive is Harvoni without insurance?

Prices are for cash paying customers only and are not valid with insurance plans. This corresponds to an average cost of $1,175 per pill, $65,000 for an 8-week treatment course, $98,500 for a 12-week treatment course, and $197,000 for a 24-week course.

How much does Epclusa cost per pill?

The cost for Epclusa oral pellet (150 mg-37.5 mg) is around $26,250 for a supply of 28 pellet, depending on the pharmacy you visit….Oral Tablet.

Quantity Per unit Price
28 $937.51 $26,250.26

How can I get hep C treatment for free?

Patient assistance programs (PAPs) offer free hepatitis C drugs to lower-income people who are uninsured or underinsured, and who do not qualify for insurance programs such as Medicaid or Medicare.

How much does generic Harvoni cost?

The cost for Harvoni oral pellet (33.75 mg-150 mg) is around $33,179 for a supply of 28 pellet, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans….Oral Tablet.

Quantity Per unit Price
28 $1,184.96 $33,179.00

Why is hep C medicine so expensive?

Hepatitis C drugs are expensive due to the large demand for them, and the high cost of bringing them to market. Developing a new drug, testing it in clinical trials, and marketing it can run pharmaceutical companies nearly $900 million.

How much is a 12-week supply of Epclusa?

Gilead has priced a 12-week regimen of Epclusa to cost $74,760. The cost of Epclusa is in-line with, if not a little less than, the other 12-week Hepatitis C medication regimens currently on the market such as Sovaldi and Harvoni which cost $84,000 and $94,500 respectively.

How much does Epclusa 400 mg cost?

Your monthly Epclusa cost savings if eligible

Strength Avg. monthly price at a US pharmacy NiceRx monthly price
400/100mg 28 tablets $25,600.00 $49.00

What is the best hep C treatment?

Hepatitis C is treated using direct-acting antiviral (DAA) tablets. DAA tablets are the safest and most effective medicines for treating hepatitis C. They’re highly effective at clearing the infection in more than 90% of people.